Instil Bio, Inc.
TIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $124,279 | $49,560 | $81,593 | $1,813,544 |
| - Cash | $8,805 | $9,195 | $43,716 | $37,590 |
| + Debt | $86,886 | $86,054 | $79,902 | $0 |
| Enterprise Value | $202,360 | $126,419 | $117,779 | $1,775,954 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$5,987 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$62,528 | -$147,117 | -$217,380 | -$152,514 |
| % Margin | – | – | – | – |
| Net Income | -$74,135 | -$156,087 | -$223,177 | -$156,794 |
| % Margin | – | – | – | – |
| EPS Diluted | -11.39 | -24 | -34.46 | -29.6 |
| % Growth | 52.5% | 30.4% | -16.4% | – |
| Operating Cash Flow | -$55,696 | -$82,029 | -$180,164 | -$122,138 |
| Capital Expenditures | -$10,000 | -$20,663 | -$84,589 | -$57,831 |
| Free Cash Flow | -$65,696 | -$102,692 | -$264,753 | -$179,969 |